Medication info
Hugliya Tablet 25 mg (Sitagliptin Hydrochloride Hydrate)

Hugliya Tablet 25 mg (Sitagliptin Hydrochloride Hydrate)

Prescription medicationTablet경구
Ingredient · strength
Sitagliptin Hydrochloride Hydrate›28.34mg / 1 tablet
Manufacturer / importer
(주)휴온스
Appearance
Bright yellow-orange round film-coated tablet
Packaging
100 tablets/bottle, 30 tablets/bottle
Approval status
Active

MFDS item code 202102408 · Approved 2021.03.17 · Insurance code 670609000

Summary

Main use
Improvement of blood sugar control in type 2 diabetes
Who takes it
Adults
Adult dose
This medication is administered once daily at a dose of 100 mg for monotherapy or combined therapy, with a maximum daily dose of 100 mg. It can be taken irrespective of meals. In patients with renal impairment, dosage adjustment is necessary according to kidney function. There is no need for dosage adjustment in patients with mild to moderate renal impairment (eGFR 45 or higher but less than 90). In patients with moderate renal impairment (eGFR 30 or more but less than 45), a dose of 50 mg is administered once daily.

Ingredients

Manufacturer
(주)휴온스

Efficacy & effects

Improvement of blood sugar control in type 2 diabetes

  • Difficulty in blood sugar control in patients with type 2 diabetes
View approved original text

This medication helps control blood sugar levels in patients with type 2 diabetes. It is used as an adjunct to diet and exercise therapy and can also be taken alone. If patients have not previously taken diabetes medications or have difficulty controlling blood sugar with monotherapy, it may be taken together with metformin. Additionally, in cases where treatment with sulfonylureas, metformin, thiazolidinediones, or insulin alone is insufficient, this medication can be combined to enhance blood sugar control. It may also be used additionally for patients who have difficulty controlling blood sugar with various drug combinations. This medication aids in improving blood sugar control in various therapeutic scenarios.

How to take

Adult dose

This medication is administered once daily at a dose of 100 mg for monotherapy or combined therapy, with a maximum daily dose of 100 mg. It can be taken irrespective of meals. In patients with renal impairment, dosage adjustment is necessary according to kidney function. There is no need for dosage adjustment in patients with mild to moderate renal impairment (eGFR 45 or higher but less than 90). In patients with moderate renal impairment (eGFR 30 or more but less than 45), a dose of 50 mg is administered once daily.

Precautions

This medication may cause severe allergic reactions after administration, so if symptoms such as skin rashes or breathing difficulties occur, it should be discontinued immediately and medical advice should be sought. There is also a risk of serious pancreatic inflammation known as pancreatitis, so if symptoms such as abdominal pain, nausea, or vomiting appear, it is important to visit a hospital quickly. This medication should not be used in patients with type 1 diabetes or those who have specific allergic reactions. Patients with impaired kidney function may experience drug accumulation in the body; therefore, dosage adjustment or cautious use is necessary, and periodic kidney function tests are recommended. Due to the risk of hypoglycemia, caution should be exercised when taking it with other antidiabetic agents like insulin or sulfonylureas, and dosage adjustments may be necessary if required. Severe joint pain or skin blistering has been reported on rare occasions; if such symptoms occur, contact a doctor immediately. It is recommended that pregnant or breastfeeding women do not take this medication, and safety has not been established in children under 18 years of age. In the case of overdose, appropriate treatment should be initiated, such as gastrointestinal decontamination and cardiac monitoring, and blood dialysis may be conducted if necessary to remove some of the medication.

Side effects and when to seek care immediately

Serious side effects

Hives, severe swelling (angioedema), chest tightness, difficulty breathing, cold sweat, pallor (severe allergic reaction), rash, exfoliative skin disease, Stevens-Johnson syndrome, skin peeling, pain in mouth/eye mucosa (severe skin adverse reactions), shortness of breath or difficulty breathing, asthma attacks, abnormalities in breathing accompanied by cough and fever, liver-related symptoms (jaundice) are not specifically mentioned, but include elevated liver enzymes.

Mild side effects

  • Upper respiratory tract infection
  • nasopharyngitis
  • constipation
  • vomiting
  • headache
  • muscle pain
  • limb pain
  • back pain
  • pruritus
  • thrombocytopenia
Show 10 more
  • diarrhea
  • dyspepsia
  • dizziness
  • increased triglycerides
  • increased low-density lipoprotein
  • hyperglycemia
  • weight loss
  • hypertension
  • hypernatremia
  • erectile dysfunction.

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a sealed container to prevent exposure to air or moisture. It is also important to avoid excessively hot or cold places, and it is best to store it at room temperature between 1°C and 30°C.

Appearance and packaging

Appearance

Bright yellow-orange round film-coated tablet

Package unit

100 tablets/bottle, 30 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.